These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 20692050

  • 1. Association to the Glypican-5 gene in multiple sclerosis.
    Lorentzen AR, Melum E, Ellinghaus E, Smestad C, Mero IL, Aarseth JH, Myhr KM, Celius EG, Lie BA, Karlsen TH, Franke A, Harbo HF.
    J Neuroimmunol; 2010 Sep 14; 226(1-2):194-7. PubMed ID: 20692050
    [Abstract] [Full Text] [Related]

  • 2. Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis.
    Nischwitz S, Cepok S, Kroner A, Wolf C, Knop M, Müller-Sarnowski F, Pfister H, Roeske D, Rieckmann P, Hemmer B, Ising M, Uhr M, Bettecken T, Holsboer F, Müller-Myhsok B, Weber F.
    J Neuroimmunol; 2010 Oct 08; 227(1-2):162-6. PubMed ID: 20598377
    [Abstract] [Full Text] [Related]

  • 3. Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases.
    Shin JG, Kim HJ, Park BL, Bae JS, Kim LH, Cheong HS, Shin HD.
    J Neurol Sci; 2013 Dec 15; 335(1-2):82-8. PubMed ID: 24135429
    [Abstract] [Full Text] [Related]

  • 4. Glypican 5 is an interferon-beta response gene: a replication study.
    Cénit MD, Blanco-Kelly F, de las Heras V, Bartolomé M, de la Concha EG, Urcelay E, Arroyo R, Martínez A.
    Mult Scler; 2009 Aug 15; 15(8):913-7. PubMed ID: 19556317
    [Abstract] [Full Text] [Related]

  • 5. The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility.
    Bahreini SA, Jabalameli MR, Saadatnia M, Zahednasab H.
    J Neuroimmunol; 2010 Dec 15; 229(1-2):5-15. PubMed ID: 20832869
    [Abstract] [Full Text] [Related]

  • 6. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.
    Rubio JP, Stankovich J, Field J, Tubridy N, Marriott M, Chapman C, Bahlo M, Perera D, Johnson LJ, Tait BD, Varney MD, Speed TP, Taylor BV, Foote SJ, Butzkueven H, Kilpatrick TJ.
    Genes Immun; 2008 Oct 15; 9(7):624-30. PubMed ID: 18650830
    [Abstract] [Full Text] [Related]

  • 7. Genome-wide association analysis in primary sclerosing cholangitis.
    Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, Lie BA, Bergquist A, Schramm C, Weismüller TJ, Gotthardt D, Rust C, Philipp EE, Fritz T, Henckaerts L, Weersma RK, Stokkers P, Ponsioen CY, Wijmenga C, Sterneck M, Nothnagel M, Hampe J, Teufel A, Runz H, Rosenstiel P, Stiehl A, Vermeire S, Beuers U, Manns MP, Schrumpf E, Boberg KM, Schreiber S.
    Gastroenterology; 2010 Mar 15; 138(3):1102-11. PubMed ID: 19944697
    [Abstract] [Full Text] [Related]

  • 8. More CLEC16A gene variants associated with multiple sclerosis.
    Nischwitz S, Cepok S, Kroner A, Wolf C, Knop M, Müller-Sarnowski F, Pfister H, Rieckmann P, Hemmer B, Ising M, Uhr M, Bettecken T, Holsboer F, Müller-Myhsok B, Weber F.
    Acta Neurol Scand; 2011 Jun 15; 123(6):400-6. PubMed ID: 20849399
    [Abstract] [Full Text] [Related]

  • 9. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis.
    Hoppenbrouwers IA, Aulchenko YS, Janssens AC, Ramagopalan SV, Broer L, Kayser M, Ebers GC, Oostra BA, van Duijn CM, Hintzen RQ.
    J Hum Genet; 2009 Nov 15; 54(11):676-80. PubMed ID: 19834503
    [Abstract] [Full Text] [Related]

  • 10. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
    Burfoot RK, Jensen CJ, Field J, Stankovich J, Varney MD, Johnson LJ, Butzkueven H, Booth D, Bahlo M, Tait BD, Taylor BV, Speed TP, Heard R, Stewart GJ, Foote SJ, Kilpatrick TJ, Rubio JP.
    Tissue Antigens; 2008 Jan 15; 71(1):42-50. PubMed ID: 17971048
    [Abstract] [Full Text] [Related]

  • 11. Risk alleles for multiple sclerosis in multiplex families.
    D'Netto MJ, Ward H, Morrison KM, Ramagopalan SV, Dyment DA, DeLuca GC, Handunnetthi L, Sadovnick AD, Ebers GC.
    Neurology; 2009 Jun 09; 72(23):1984-8. PubMed ID: 19506219
    [Abstract] [Full Text] [Related]

  • 12. EVI5 is a risk gene for multiple sclerosis.
    Hoppenbrouwers IA, Aulchenko YS, Ebers GC, Ramagopalan SV, Oostra BA, van Duijn CM, Hintzen RQ.
    Genes Immun; 2008 Jun 09; 9(4):334-7. PubMed ID: 18401352
    [Abstract] [Full Text] [Related]

  • 13. A new association between polymorphisms of the SLC6A7 gene in the chromosome 5q31-32 region and asthma.
    Kim JH, Cheong HS, Park BL, Bae JS, Jung S, Yoon SH, Park JS, Jang AS, Park SW, Uh ST, Kim YH, Hwang HK, Park CS, Shin HD.
    J Hum Genet; 2010 Jun 09; 55(6):358-65. PubMed ID: 20431603
    [Abstract] [Full Text] [Related]

  • 14. Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression.
    Kantarci OH, Hebrink DD, Schaefer-Klein J, Sun Y, Achenbach S, Atkinson EJ, Heggarty S, Cotleur AC, de Andrade M, Vandenbroeck K, Pelfrey CM, Weinshenker BG.
    Arch Neurol; 2008 Mar 09; 65(3):349-57. PubMed ID: 18332247
    [Abstract] [Full Text] [Related]

  • 15. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.
    Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sørensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A.
    Tissue Antigens; 2004 Mar 09; 63(3):237-47. PubMed ID: 14989713
    [Abstract] [Full Text] [Related]

  • 16. Linkage disequilibrium analyses within chromosome 19p in multiple sclerosis.
    Vyshkina T, Kalman B.
    Mult Scler; 2008 May 09; 14(4):433-9. PubMed ID: 18208878
    [Abstract] [Full Text] [Related]

  • 17. Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes.
    Cortes A, Field J, Glazov EA, Hadler J, ANZgene Consortium, Stankovich J, Brown MA.
    Hum Mol Genet; 2013 Jun 01; 22(11):2283-92. PubMed ID: 23406874
    [Abstract] [Full Text] [Related]

  • 18. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
    Byun E, Caillier SJ, Montalban X, Villoslada P, Fernández O, Brassat D, Comabella M, Wang J, Barcellos LF, Baranzini SE, Oksenberg JR.
    Arch Neurol; 2008 Mar 01; 65(3):337-44. PubMed ID: 18195134
    [Abstract] [Full Text] [Related]

  • 19. Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences.
    Kochi Y, Yamada R, Kobayashi K, Takahashi A, Suzuki A, Sekine A, Mabuchi A, Akiyama F, Tsunoda T, Nakamura Y, Yamamoto K.
    Arthritis Rheum; 2004 Jan 01; 50(1):63-71. PubMed ID: 14730600
    [Abstract] [Full Text] [Related]

  • 20. Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients.
    Weber F, Cepok S, Wolf C, Berthele A, Uhr M, Bettecken T, Buck D, Hartung HP, Holsboer F, Müller-Myhsok B, Hemmer B.
    Pharmacogenomics J; 2012 Jun 01; 12(3):238-45. PubMed ID: 21502966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.